기관지 밸브(EBV) 시장 규모 조사 : 제품 유형별, 최종 사용자별, 지역별 예측(2022-2032년)

Global Endobronchial Valves Market is valued approximately at USD 171.15 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2024-2032. Endobronchial valves are medical devices used primarily to treat severe emphysema, a form of chronic obstructive pulmonary disease (COPD). These small, one-way valves are implanted in the airways of the lungs using a minimally invasive bronchoscopy procedure. Once in place, they allow air to exit the over-inflated, diseased parts of the lungs but prevent air from entering these areas. This process reduces lung hyperinflation and redirects airflow to healthier parts of the lung, thereby improving breathing efficiency. By relieving pressure and reducing the volume of the diseased lung sections, endobronchial valves help enhance overall lung function, alleviate symptoms like shortness of breath, and improve the patient's quality of life. The procedure is generally considered for patients who are not candidates for more invasive surgical interventions like lung volume reduction surgery or lung transplantation. The increasing prevalence of lung-related health issues, notably chronic obstructive pulmonary disease (COPD), is driving the demand for innovative medical devices like endobronchial valves. COPD is a leading cause of mortality, claiming approximately 3 million lives annually, according to the American Journal of Respiratory and Critical Care Medicine. This alarming statistic underscores the need for effective treatment options, including minimally invasive procedures facilitated by endobronchial valves, which are increasingly preferred over traditional open surgeries due to reduced trauma.

The Endobronchial Valves Market is also bolstered by the significant number of clinical trials focused on COPD, as reported by the WHO International Clinical Trials Registry Platform, with over 600 ongoing studies. This active research landscape highlights the growing interest and investment in discovering new treatment methodologies for COPD, which is expected to propel the endobronchial valves market forward. For instance, a study published in MDPI in November 2022 emphasized the advancements in bronchoscopic management for COPD, reflecting the ongoing efforts to enhance therapeutic options in this field. Moreover, rising awareness about bronchoscopic lung volume reduction as a viable treatment for lung-related health issues is further driving the market. However, the high cost associated with bronchoscopic valves, driven by the limited number of market players, poses a challenge to broader market expansion.

The key regions considered for the Global Endobronchial Valves Market study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa, North America held the largest market share in 2023, driven by the high prevalence of COPD and robust healthcare infrastructure. The region's focus on clinical trials and innovative treatments, alongside FDA approvals for devices like Zephyr and Spiration valves, reinforces its market dominance. The Asia Pacific region is expected to grow rapidly due to the aging population and increasing incidence of lung diseases, driven by factors such as air pollution and occupational hazards.

Major market players included in this report are:

• Pulmonx Corporation
• Olympus Corporation
• Spiration Inc. (a subsidiary of Olympus)
• Boston Scientific Corporation
• Medtronic plc
• Merit Medical Systems, Inc.
• Broncus Medical Inc.
• ALung Technologies, Inc.
• BTG International Ltd. (a subsidiary of Boston Scientific)
• PneumRx, Inc. (a BTG company)
• Innovative Airway Solutions
• IntraPace, Inc.
• Uptake Medical Corporation
• Novatech SA
• TARIS Biomedical LLC

The detailed segments and sub-segment of the market are explained below:

By Product Type:

• Duckbill-Shaped
• Umbrella-Shaped

By End User:

• Hospitals
• Clinical Research Center
• Ambulatory Surgery Center
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Endobronchial Valves Market Executive Summary

• 1.1. Global Endobronchial Valves Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product Type
  • 1.3.2. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Endobronchial Valves Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Endobronchial Valves Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising Prevalence of Lung-Related Issues
  • 3.1.2. Increasing Tobacco Consumption and smoking rate
• 3.2. Market Challenges
  • 3.2.1. High Cost of Bronchoscopic Valves
• 3.3. Market Opportunities
  • 3.3.1. Technological Advancements in Medical Devices
  • 3.3.2. Growing Clinical Trials for COPD Treatments

Chapter 4. Global Endobronchial Valves Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunity
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Endobronchial Valves Market Size & Forecasts by Product Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Endobronchial Valves Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 5.2.1. Duckbill-Shaped
  • 5.2.2. Umbrella-Shaped

Chapter 6. Global Endobronchial Valves Market Size & Forecasts by End User 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Endobronchial Valves Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 6.2.1. Hospitals
  • 6.2.2. Clinical Research Center
  • 6.2.3. Ambulatory Surgery Center
  • 6.2.4. Others

Chapter 7. Global Endobronchial Valves Market Size & Forecasts by Region 2022-2032

• 7.1. North America Endobronchial Valves Market
  • 7.1.1. U.S. Endobronchial Valves Market
    • 7.1.1.1. Product Type breakdown size & forecasts, 2022-2032
    • 7.1.1.2. End User breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Endobronchial Valves Market
• 7.2. Europe Endobronchial Valves Market
  • 7.2.1. UK Endobronchial Valves Market
  • 7.2.2. Germany Endobronchial Valves Market
  • 7.2.3. France Endobronchial Valves Market
  • 7.2.4. Italy Endobronchial Valves Market
  • 7.2.5. Netherlands Endobronchial Valves Market
  • 7.2.6. Spain Endobronchial Valves Market
  • 7.2.7. Russia Endobronchial Valves Market
  • 7.2.8. Rest of Europe Endobronchial Valves Market
• 7.3. Asia-Pacific Endobronchial Valves Market
  • 7.3.1. China Endobronchial Valves Market
  • 7.3.2. India Endobronchial Valves Market
  • 7.3.3. Japan Endobronchial Valves Market
  • 7.3.4. Malaysia Endobronchial Valves Market
  • 7.3.5. Indonesia Endobronchial Valves Market
  • 7.3.6. South Korea Endobronchial Valves Market
  • 7.3.7. Rest of Asia Pacific Endobronchial Valves Market
• 7.4. Latin America Endobronchial Valves Market
  • 7.4.1. Brazil Endobronchial Valves Market
  • 7.4.2. Mexico Endobronchial Valves Market
  • 7.4.3. Argentina Endobronchial Valves Market
  • 7.4.4. Rest of Latin America Endobronchial Valves Market
• 7.5. Middle East & Africa Endobronchial Valves Market
  • 7.5.1. Saudi Arabia Endobronchial Valves Market
  • 7.5.2. UAE Endobronchial Valves Market
  • 7.5.3. Israel Endobronchial Valves Market
  • 7.5.4. South Africa Endobronchial Valves Market
  • 7.5.5. Rest of Middle East & Africa Endobronchial Valves Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Pulmonx Corporation
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Olympus Corporation
  • 8.3.3. Spiration Inc. (a subsidiary of Olympus)
  • 8.3.4. Boston Scientific Corporation
  • 8.3.5. Medtronic plc
  • 8.3.6. Merit Medical Systems, Inc.
  • 8.3.7. Broncus Medical Inc.
  • 8.3.8. ALung Technologies, Inc.
  • 8.3.9. BTG International Ltd. (a subsidiary of Boston Scientific)
  • 8.3.10. PneumRx, Inc. (a BTG company)
  • 8.3.11. Innovative Airway Solutions
  • 8.3.12. IntraPace, Inc.
  • 8.3.13. Uptake Medical Corporation
  • 8.3.14. Novatech SA
  • 8.3.15. TARIS Biomedical LLC

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes